|
Post by rickf on Jan 7, 2023 8:18:05 GMT -5
I hear you but, I also disagree with your projections. This was just .88 not too long ago, in the bigger picture and it's now almost up 5X from the bottom...more recently, +33.23% YTD while the S&P 500 is +20.93%, NASDAQ 100 +21.75% and the DJIA +13.32%. MNKD has outperformed all three averages YTD. I can't predict what the future holds for MNKD or the indices but one thing is certain...I like the trend, coming catalysts, recent refinancing and coming increase in revenue stream from the UTHR partnership. Those alone can easily push this up another $3. The only question is how long can it stay there? Projections - hmmm -- it has gone up hugely from the .88 but it fell from a presplit price of $37!! Like I said - I'll be dead before this ship turns around! I'll stick with my doubt that it will go up even $3 in 3 years! PLEASE prove me wrong - begging here!! Thank you to the stock gods for proving me wrong! Now --- PLEASE prove me REALLY wrong and take this share price to $38.00!!
|
|
|
Post by stockwhisperer on Jan 7, 2023 9:31:05 GMT -5
I am a long term investor of MNKD, w/a large investment, going back to when Afrezza was approved. I think, in general, reverse splits in the biotech world are not that uncommon. Certainly other type companies do them too. While maybe more of an anomaly, two companies that very quickly did well via reserve splits were Citibank (C) and not that long ago - Sept 2022, NRBO… www.forbes.com/sites/qai/2022/09/14/neurobo-pharmaceuticals-nrbo-stock-soared-after-a-stock-split/?sh=521703d259f4. From an investment standpoint, an advance plan - entry - exit and everything in between - prior to buying a stock, is good. For example, making limit buys on different days and not all at the same time. Even if all buys are made prior to a reverse split being announced - having enough funds to average down - just in case, is probably always a good idea. You know the saying about putting all the eggs in one basket. I have done that - knowing full well that it is not a smart move - certainly not for a retiree, such as myself. I have no doubt that diversifying is the right way to go. In any case, the opportunities to average down with MNKD, imho, have been abundant. Sometimes it might even be worth it to sell shares at a higher sp and buy them back at a lower price or just taking a loss on some. I did take buying opps to average down. It just depends on how each person follows their personal investment plan and how or if they chose to adjust their strategy. In one IRA, I was able to average down to $3.65. In the other IRA, I averaged near $8.23. While I am satisfied, I wish I could have done better in both IRAs but I made mistakes. Overall, I am very pleased with where it appears MNKD is headed. GL to you and others in their decision making about what to do. I think MNKD continues to be ridiculously undervalued so, anyone of that mindset that has the funds - might, based on their own DD, continue to take opportunities to average down. Best of luck!
|
|